GENOMINES

Genomines is a biotechnology and agriculture company that grows nickel with genetically enhanced hyperaccumulator plants, which extract the metal from low-grade or polluted soils. The company describes its approach as "metal farms" intended to supply battery-grade nickel at lower cash cost and emissions than traditional mining.

The company presents its output as battery-grade nickel for critical metal supply chains. Its public materials describe the business as producing metal for industrial buyers rather than end consumers; no pricing or customer names are given on the website.

Genomines lists its headquarters in Paris, France, with a second office in Johannesburg, South Africa. The website reports a $45M Series A announced in January 2026 and names investors including Engine Ventures, Forbion and DTCF. Open roles are in Les Ulis, France, covering research, plant production, operations and executive support.

Product: Nickel produced through hyperaccumulator plants grown on "metal farms" to extract metal from low-grade soils.